BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3716924)

  • 21. Preliminary assessment of luteolin as an affinity ligand for type II estrogen--binding sites in rat uterine nuclear extracts.
    Markaverich BM; Gregory RR
    Steroids; 1993 Jun; 58(6):268-74. PubMed ID: 8212072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoplasmic estrogen receptors of rat mammary glands during pregnancy and puerperium.
    Hoshiai H; Takahashi K; Furuhashi N; Wada Y; Uehara S; Suzuki M
    Tohoku J Exp Med; 1982 Feb; 136(2):195-202. PubMed ID: 7071838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrogen receptor of mammary gland. Inhibition of aggregation and characterization of receptor from lactating gland in the presence of sodium bromide.
    Auricchio F; Rotondi A; Schiavone E; Bresciani F
    Biochem J; 1978 Mar; 169(3):481-8. PubMed ID: 646787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition.
    Markaverich BM; Roberts RR; Alejandro MA; Johnson GA; Middleditch BS; Clark JH
    J Steroid Biochem; 1988; 30(1-6):71-8. PubMed ID: 3386279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. delta9-Tetrahydrocannabinol and 17beta-estradiol bind to different macromolecules in estrogen target tissues.
    Okey AB; Bondy GP
    Science; 1978 Apr; 200(4339):312-4. PubMed ID: 635586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of glucocorticoid-binding proteins in normal and neoplastic mammary tissues of the rat.
    Goral JE; Wittliff JL
    Biochemistry; 1975 Jul; 14(13):2944-52. PubMed ID: 238578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multi-component system of estrogen binding proteins from the liver: characterization of binding properties of high molecular weight protein from rat liver similar to uterine estradiol receptors].
    Mataradze GD; Rukaĭia MKh; Smirnov AN; Rozen VB
    Biokhimiia; 1979 Aug; 44(8):1484-92. PubMed ID: 497294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
    Carlson RA; Gorski J
    Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen binding in mammary tissue of C3H mice with or without the mouse mammary tumor virus.
    Bondy GP; Okey AB
    Oncology; 1978; 35(3):127-31. PubMed ID: 209378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the cytosolic estrogen receptor in rat skeletal muscle.
    Dahlberg E
    Biochim Biophys Acta; 1982 Jul; 717(1):65-75. PubMed ID: 7104393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of oxytocin receptors in the uterus and mammary gland.
    Soloff MS; Schroeder BT; Chakraborty J; Pearlmutter AF
    Fed Proc; 1977 May; 36(6):1861-6. PubMed ID: 192601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin and estrogen binding sites in the mammary gland of the lactating and non-lactating rat.
    Bohnet HG; Gómez F; Friesen HG
    Endocrinology; 1977 Oct; 101(4):1111-21. PubMed ID: 198196
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
    Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
    J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK; Kohler D
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of estradiol binding components in hamster uterine nuclei.
    Okulicz WC; Evans RW; Leavitt WW
    Biochim Biophys Acta; 1981 Oct; 677(2):253-6. PubMed ID: 7197556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid-hormone-binding proteins in normal and neoplastic mammary tissues from C3H mice fed diethylstilbestrol.
    Lewko WM; Wittliff JL
    J Toxicol Environ Health; 1983 Jul; 12(1):127-41. PubMed ID: 6632000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential response of individual uterine cell types from immature rats treated with estradiol.
    McCormack SA; Glasser SR
    Endocrinology; 1980 May; 106(5):1634-49. PubMed ID: 6153974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.